Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
Hao Wu(Stanford Medicine), Fredrik Bäckhed(Sahlgrenska University Hospital), Matteo Sérino(University of Rome Tor Vergata), Lisa Olsson(Wallenberg Wood Science Center), Rémy Burcelin(Institut des Maladies Métaboliques et Cardiovasculaires), Gemma Xifra(Universitat de Girona), Rosie Perkins(Wallenberg Wood Science Center), Mercè Planas-Fèlix(Barcelona Supercomputing Center), Valentina Tremaroli(University of Gothenburg), Louise Mannerås-Holm(Wallenberg Wood Science Center), David Torrents(Barcelona Supercomputing Center), José Manuel Fernández‐Real(Universitat de Girona), Robert Caesar(Wallenberg Wood Science Center), Josep M. Mercader(Institut d'Investigació Biomédica de Bellvitge), Muhammad Tanweer Khan(Wallenberg Wood Science Center), Eduardo Esteve(Universitat de Girona), Marcus Ståhlman(University of Gothenburg), Wifredo Ricart
Cited by 1,626
Related Papers
Enterotypes of the human gut microbiome
|Nature|2011|7.6k
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
|Nature|2011|1.5k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Enterotypes in the landscape of gut microbial community composition
|Nature Microbiology|2017|1.2k
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
|Endocrine Reviews|2003|876